Blood test to detect Alzheimer's disease will be trialled in Australia

Diagnosing Alzheimer's disease currently requires either a PET scan or a lumbar puncture, both of which can be expensive and inaccessible for those with symptoms. Clinicians, researchers, government and industry partners have come together in a new arrangement to trial a blood test that uses biomarkers for the disease, in the hope it will aid diagnosis.Guest/sProfessor Matthew Kiernan, Chief Executive Officer and Institute Director, NeuRA (Neuroscience Research Australia) ReferencesTest that could identify signs of Alzheimer's disease 20 years earlier greenlit for trials